Atlas Trials

Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome

Clinical trial NCT03571516 · COMPLETED

Trial details

NCT number
NCT03571516
Sponsor
Shire
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Short Bowel Syndrome
Start date
2018-08-31
Primary completion
2020-09-24
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.